{"id":368620,"date":"2025-09-01T16:14:07","date_gmt":"2025-09-01T16:14:07","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-fennec-pharmaceuticals\/"},"modified":"2025-09-01T16:14:07","modified_gmt":"2025-09-01T16:14:07","slug":"how-to-buy-fennec-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/","title":{"rendered":"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-368620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Fennec Pharmaceuticals Inc. (FRX) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i biyoteknoloji \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse fiyat\u0131n\u0131, ticaret stratejilerini ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Fennec Pharmaceuticals Inc. (FRX) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i biyoteknoloji \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse fiyat\u0131n\u0131, ticaret stratejilerini ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"\u00c7ocuklar\u0131n i\u015fitmesini ger\u00e7ekten kurtaran bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Fennec Pharmaceuticals (FRX), \u015fu anda biyoteknolojide en etkileyici hikayelerden birini temsil ediyor. Pediatrik kanser hastalar\u0131nda i\u015fitme kayb\u0131n\u0131 \u00f6nleyen \u00e7\u0131\u011f\u0131r a\u00e7an PEDMARK ilac\u0131yla, bu sadece ba\u015fka bir ila\u00e7 hissesi de\u011fil\u2014misyon odakl\u0131 bir yat\u0131r\u0131m f\u0131rsat\u0131. Dahil olmak i\u00e7in bilmeniz gereken her \u015feyi birlikte inceleyelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u00c7ocuklar\u0131n i\u015fitmesini ger\u00e7ekten kurtaran bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Fennec Pharmaceuticals (FRX), \u015fu anda biyoteknolojide en etkileyici hikayelerden birini temsil ediyor. Pediatrik kanser hastalar\u0131nda i\u015fitme kayb\u0131n\u0131 \u00f6nleyen \u00e7\u0131\u011f\u0131r a\u00e7an PEDMARK ilac\u0131yla, bu sadece ba\u015fka bir ila\u00e7 hissesi de\u011fil\u2014misyon odakl\u0131 bir yat\u0131r\u0131m f\u0131rsat\u0131. Dahil olmak i\u00e7in bilmeniz gereken her \u015feyi birlikte inceleyelim."},"body_html":"<h2>\ud83d\udcc8 Fennec Pharmaceuticals Hisse Senedi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>1 Eyl\u00fcl 2025 itibar\u0131yla, Fennec Pharmaceuticals Inc. (FRX) piyasada <strong>12,36 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Ancak as\u0131l \u00f6nemli olan \u015fu: <strong>5 Kas\u0131m 2025<\/strong>, ticaret takviminizde k\u0131rm\u0131z\u0131yla i\u015faretlemeniz gereken bir sonraki b\u00fcy\u00fck tarih. Bu tarihte Fennec, 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu t\u00fcr olaylar\u0131n hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkiledi\u011fi g\u00f6r\u00fclm\u00fc\u015ft\u00fcr.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 FRX Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Son performansa bak\u0131ld\u0131\u011f\u0131nda, Fennec'in 14 A\u011fustos 2025 tarihli 2. \u00e7eyrek kazan\u00e7lar\u0131 \u00f6nemli bir ivme yaratt\u0131. \u015eirket, <a href=\"https:\/\/www.nasdaq.com\/press-release\/fennec-pharmaceuticals-reports-second-quarter-2025-financial-results-and-provides\">9,7 milyon $ toplam net gelir<\/a> bildirdi ve bu, y\u0131ll\u0131k bazda \u015fa\u015f\u0131rt\u0131c\u0131 bir %33 art\u0131\u015f anlam\u0131na geliyor. Bu t\u00fcr bir b\u00fcy\u00fcme e\u011filimi, biyoteknoloji hisselerinde zamanlaman\u0131n neden \u00f6nemli oldu\u011funu size anlat\u0131yor.<\/p> <p>Desen a\u00e7\u0131k: olumlu klinik deneme sonu\u00e7lar\u0131 ve g\u00fc\u00e7l\u00fc kazan\u00e7lar FRX'i s\u00fcrekli yukar\u0131 ta\u015f\u0131yor. Bu y\u0131l\u0131n ba\u015flar\u0131nda <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/02\/07\/3022701\/0\/en\/Fennec-Pharmaceuticals-Announces-Commercial-Launch-of-PEDMARQSI-In-Germany.html\">Almanya'daki ticari lansmanlar\u0131n\u0131<\/a> duyurduklar\u0131nda, hisse yat\u0131r\u0131mc\u0131 g\u00fcveniyle tepki verdi.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Belirsizlikten \u0130vmeye<\/h2> <p>Fennec'in hissesi son alt\u0131 ayda olduk\u00e7a dalgal\u0131 bir seyir izledi ve bu yolculu\u011fu anlamak potansiyel yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ok \u00f6nemli.<\/p> <p><strong>Ocak-Mart 2025<\/strong>: Hisse, yat\u0131r\u0131mc\u0131lar Avrupa geni\u015fleme planlar\u0131 hakk\u0131nda netlik beklerken 7-8 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc. Bu, ak\u0131ll\u0131 paran\u0131n pozisyon almaya ba\u015flad\u0131\u011f\u0131 birikim a\u015famas\u0131yd\u0131.<\/p> <p><strong>Nisan-Haziran 2025<\/strong>: <a href=\"https:\/\/www.pharmaceutical-technology.com\/news\/norgine-secures-pedmarqsi-licence-from-fennec-in-deal-worth-up-to-272m\/\">Norgine ile ortakl\u0131k anla\u015fmalar\u0131<\/a> sonu\u00e7 vermeye ba\u015flay\u0131nca ivme artt\u0131. Hisse fiyat\u0131 istikrarl\u0131 \u015fekilde 10-11 $ aral\u0131\u011f\u0131na y\u00fckseldi.<\/p> <p><strong>Temmuz-Eyl\u00fcl 2025<\/strong>: Patlama b\u00f6lgesi! 2. \u00e7eyrek kazan\u00e7lar beklentileri a\u015farken ve <a href=\"https:\/\/hearinghealthmatters.org\/hearing-news-watch\/2025\/pedmarqsi-hearing-loss-prevention-cisplatin\/\">klinik do\u011frulamalar artarken<\/a>, FRX 12 $'\u0131n \u00fczerine \u00e7\u0131karak Ocak diplerinden %60'tan fazla b\u00fcy\u00fcme g\u00f6sterdi.<\/p> <p>\u00d6nemli \u00e7\u0131kar\u0131m? Bu rastgele bir volatilite de\u011fil\u2014\u015firket b\u00fcy\u00fcme stratejisini hassasiyetle uyguluyor. Her fiyat hareketi somut i\u015f kilometre ta\u015flar\u0131na kar\u015f\u0131l\u0131k geldi.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <p>Mevcut ivme ve analist projeksiyonlar\u0131na dayanarak, Fennec Pharmaceuticals i\u00e7in gelecek yol \u015f\u00f6yle g\u00f6r\u00fcn\u00fcyor:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 15-18 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %20-45 yukar\u0131 potansiyel)<br> Avrupa geni\u015flemesi ve olas\u0131 Japonya deneme sonu\u00e7lar\u0131n\u0131n y\u0131l sonu ivmesi i\u00e7in m\u00fckemmel ko\u015fullar yaratmas\u0131 bekleniyor.<\/p> <p><strong>2026 Tahmini<\/strong>: 22-26 $ <br> <a href=\"https:\/\/www.tipranks.com\/stocks\/tse:frx\/forecast\">TipRanks analistleri ortalama hedef fiyat\u0131 19,51 $ olarak projeliyor<\/a>, ancak son performans nedeniyle ben daha iyimserim. Tam Avrupa lansman\u0131 ve potansiyel Asya pazar\u0131na giri\u015f bunu destekleyebilir.<\/p> <p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 35-42 $<br> Bu noktada Fennec, farkl\u0131 b\u00f6lgelerden birden fazla gelir ak\u0131\u015f\u0131yla k\u00fcresel bir varl\u0131k olu\u015fturmu\u015f olmal\u0131.<\/p> <p><strong>2030 Vizyonu<\/strong>: 50 $ ve \u00fczeri <br> PEDMARK d\u0131\u015f\u0131ndaki \u00fcr\u00fcn hatt\u0131n\u0131 ba\u015far\u0131yla geni\u015fletir ve uzmanl\u0131k alan\u0131n\u0131 korursa, bu hedef ula\u015f\u0131labilir hale gelir.<\/p> <p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Risk-getiri oran\u0131 mevcut seviyelerde birikimi destekliyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Mali Dalgalanma<\/strong>: Fennec, <a href=\"https:\/\/simplywall.st\/stocks\/ca\/pharmaceuticals-biotech\/tsx-frx\/fennec-pharmaceuticals-shares\">geriye d\u00f6n\u00fck olarak 16,53 milyon CA$ zarar<\/a> ile hala nakit yak\u0131yor. Biyoteknoloji giri\u015fimleri her zaman bu riskle kar\u015f\u0131 kar\u015f\u0131yad\u0131r.<\/li> <li><strong>Tek \u00dcr\u00fcn Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: \u015eirketin t\u00fcm i\u015fi \u015fu anda PEDMARK\/PEDMARQSI'ye dayan\u0131yor. Herhangi bir d\u00fczenleyici engel veya rekabet tehdidi y\u0131k\u0131c\u0131 olabilir.<\/li> <li><strong>Y\u00fcksek Beta Katsay\u0131s\u0131<\/strong>: 1,92 beta ile bu hisse, genel piyasadan neredeyse iki kat daha fazla hareket ediyor. Cesaret gerektirir.<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Patlay\u0131c\u0131 B\u00fcy\u00fcme<\/strong>: <a href=\"https:\/\/www.ainvest.com\/news\/fennec-pharmaceuticals-q2-2025-earnings-call-transcript-key-highlights-financial-results-2508\/\">%33 gelir art\u0131\u015f\u0131<\/a> 2. \u00e7eyrekte ticari ba\u015far\u0131n\u0131n i\u015faretidir.<\/li> <li><strong>K\u00fcresel Geni\u015fleme<\/strong>: \u0130ngiltere ve Almanya'daki ba\u015far\u0131l\u0131 lansmanlar ortakl\u0131k modelinin i\u015fe yarad\u0131\u011f\u0131n\u0131 g\u00f6steriyor. <a href=\"https:\/\/adisinsight.springer.com\/drugs\/800006630\">2025 ikinci yar\u0131s\u0131nda beklenen Japonya deneme sonu\u00e7lar\u0131<\/a> b\u00fcy\u00fck yeni pazar a\u00e7abilir.<\/li> <li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Pediatrik onkoloji d\u00fcnya \u00e7ap\u0131nda artan ilgi ve finansman al\u0131yor.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazlas\u0131n\u0131 FRX'e ay\u0131rmay\u0131n. Volatilite sayg\u0131 gerektirir.<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferde b\u00fcy\u00fck yat\u0131r\u0131m yapmak yerine, yat\u0131r\u0131m\u0131n\u0131z\u0131 birka\u00e7 haftaya yayarak giri\u015f fiyat\u0131n\u0131z\u0131 ortalay\u0131n.<\/li> <li><strong>5 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: 3. \u00e7eyrek kazan\u00e7lar i\u00e7in takviminize i\u015faret koyun. Tarihsel olarak bu olaylar m\u00fckemmel giri\u015f noktalar\u0131 yarat\u0131r.<\/li> <li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu h\u0131zl\u0131 kar ama\u00e7l\u0131 bir hisse de\u011fil. Tam b\u00fcy\u00fcme hikayesini yakalamak i\u00e7in en az 2-3 y\u0131l tutmay\u0131 planlay\u0131n.<\/li> <\/ol> <p>Ve favori t\u00fcccar bilgeli\u011fim: \"Biyoteknoloji hisseleriyle ticaret yapmak, ergen \u00e7ocu\u011funuzun araba kullanmay\u0131 \u00f6\u011frenmesini izlemek gibidir\u2014heyecan verici ilerlemeler, hayat\u0131n\u0131z\u0131n t\u00fcm se\u00e7imlerini sorgulad\u0131\u011f\u0131n\u0131z anlarla kesintiye u\u011frar.\"<\/p> <h2>\u2705 Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Platformunuzu Se\u00e7in<\/td><td>FRX'in i\u015flem g\u00f6rd\u00fc\u011f\u00fc hem ABD hem Kanada borsalar\u0131na eri\u015fim sunan bir arac\u0131 kurum se\u00e7in<\/td><\/tr> <tr><td>2<\/td><td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Potansiyel kay\u0131plara haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n\u2014biyoteknoloji yat\u0131r\u0131m\u0131 risk ta\u015f\u0131r<\/td><\/tr> <tr><td>3<\/td><td>FRX'i Aray\u0131n<\/td><td>Kanada listesi i\u00e7in \"FRX\" veya ABD Nasdaq i\u00e7in \"FENC\" sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Piyasa emirleri yerine limit emirleri kullanarak giri\u015f fiyat\u0131n\u0131z\u0131 kontrol edin<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Ger\u00e7ekle\u015ftirin<\/td><td>Hisse adedi ve fiyat dahil emir detaylar\u0131n\u0131 iki kez kontrol edip onaylay\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option FRX Yat\u0131r\u0131m\u0131 \u0130\u00e7in Neden Mant\u0131kl\u0131?<\/h2> <p>Fennec Pharmaceuticals gibi yenilik\u00e7i \u015firketlerde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option, bu yat\u0131r\u0131m stratejisiyle m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar.<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma Tutar\u0131 5 $<\/strong> - Bu inan\u0131lmaz d\u00fc\u015f\u00fck giri\u015f engeli, FRX pozisyonunuzu \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan olu\u015fturmaya ba\u015flaman\u0131z\u0131 sa\u011flar. Bu t\u00fcr volatil bir hisse i\u00e7in k\u00fc\u00e7\u00fck ba\u015flay\u0131p kademeli b\u00fcy\u00fcmek ak\u0131ll\u0131ca bir yakla\u015f\u0131md\u0131r.<\/li> <li><strong>1 Dakikal\u0131k KYC S\u00fcreci<\/strong> - Kas\u0131m ay\u0131ndaki kazan\u00e7 kataliz\u00f6r\u00fc gibi f\u0131rsatlar\u0131 h\u0131zl\u0131ca de\u011ferlendirmek i\u00e7in h\u0131zl\u0131 do\u011frulama gerekir. Pocket Option'\u0131n sadele\u015ftirilmi\u015f do\u011frulamas\u0131, ba\u015flaman\u0131z i\u00e7in g\u00fcnlerce beklemenizi engeller.<\/li> <li><strong>100+ Para \u00c7ekme Y\u00f6ntemi<\/strong> - Karlar\u0131 periyodik olarak almak veya kazan\u00e7lar\u0131 yeniden yat\u0131rmak isteseniz de, \u00e7oklu se\u00e7enekler biyoteknoloji portf\u00f6y\u00fcn\u00fcz\u00fc y\u00f6netmede esneklik sa\u011flar.<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, FRX yat\u0131r\u0131m\u0131n\u0131z\u0131 ger\u00e7ek zamanl\u0131 grafikler ve haber ak\u0131\u015flar\u0131yla takip etmeyi kolayla\u015ft\u0131r\u0131r ve \u015firket geli\u015fmelerinden haberdar olman\u0131z\u0131 sa\u011flar.<\/p> <h2>\ud83c\udf0d 2025'te Fennec: Sadece Bir \u0130la\u00e7 Hissesi De\u011fil<\/h2> <p>Fennec Pharmaceuticals sa\u011fl\u0131k alan\u0131nda benzersiz bir konuma sahip. Kanseri tedavi etmeye \u00e7al\u0131\u015fm\u0131yorlar\u2014kanser tedavisini \u00e7ocuklar i\u00e7in daha katlan\u0131labilir hale getiriyorlar. Amiral gemisi \u00fcr\u00fcnleri PEDMARK, pediatrik hastalarda sisplatin kaynakl\u0131 i\u015fitme kayb\u0131n\u0131 \u00f6nlemek i\u00e7in FDA onayl\u0131 ilk ve tek terapiyi temsil ediyor.<\/p> <p>\u015eirketin stratejik oda\u011f\u0131 <strong>do\u011frudan tedavi yerine destekleyici bak\u0131m<\/strong> \u00fczerine. Herkes yeni kanser ila\u00e7lar\u0131 geli\u015ftirmek i\u00e7in yar\u0131\u015f\u0131rken, Fennec tedavi s\u0131ras\u0131nda ya\u015fam kalitesini koruma gibi g\u00f6zden ka\u00e7an ama kritik bir ihtiyac\u0131 belirledi.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Fennec'in y\u00f6netim ekibi Kuzey Carolina genel merkezlerinde parf\u00fcm p\u00fcsk\u00fcrten asans\u00f6rler kurdu\u2014her katta farkl\u0131 bir koku yay\u0131l\u0131yor ve \u00e7al\u0131\u015fanlar haftal\u0131k favorilerini oyluyor. \u00c7\u00fcnk\u00fc \u00e7ocuklar\u0131n i\u015fitmesini kurtar\u0131yorsan\u0131z, \u00e7al\u0131\u015fma ortam\u0131n\u0131n da harika kokmas\u0131n\u0131 neden istemeyesiniz ki?<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Fennec Pharmaceuticals Hisse Senedi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>1 Eyl\u00fcl 2025 itibar\u0131yla, Fennec Pharmaceuticals Inc. (FRX) piyasada <strong>12,36 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Ancak as\u0131l \u00f6nemli olan \u015fu: <strong>5 Kas\u0131m 2025<\/strong>, ticaret takviminizde k\u0131rm\u0131z\u0131yla i\u015faretlemeniz gereken bir sonraki b\u00fcy\u00fck tarih. Bu tarihte Fennec, 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu t\u00fcr olaylar\u0131n hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkiledi\u011fi g\u00f6r\u00fclm\u00fc\u015ft\u00fcr.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 FRX Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Son performansa bak\u0131ld\u0131\u011f\u0131nda, Fennec&#8217;in 14 A\u011fustos 2025 tarihli 2. \u00e7eyrek kazan\u00e7lar\u0131 \u00f6nemli bir ivme yaratt\u0131. \u015eirket, <a href=\"https:\/\/www.nasdaq.com\/press-release\/fennec-pharmaceuticals-reports-second-quarter-2025-financial-results-and-provides\">9,7 milyon $ toplam net gelir<\/a> bildirdi ve bu, y\u0131ll\u0131k bazda \u015fa\u015f\u0131rt\u0131c\u0131 bir %33 art\u0131\u015f anlam\u0131na geliyor. Bu t\u00fcr bir b\u00fcy\u00fcme e\u011filimi, biyoteknoloji hisselerinde zamanlaman\u0131n neden \u00f6nemli oldu\u011funu size anlat\u0131yor.<\/p>\n<p>Desen a\u00e7\u0131k: olumlu klinik deneme sonu\u00e7lar\u0131 ve g\u00fc\u00e7l\u00fc kazan\u00e7lar FRX&#8217;i s\u00fcrekli yukar\u0131 ta\u015f\u0131yor. Bu y\u0131l\u0131n ba\u015flar\u0131nda <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/02\/07\/3022701\/0\/en\/Fennec-Pharmaceuticals-Announces-Commercial-Launch-of-PEDMARQSI-In-Germany.html\">Almanya&#8217;daki ticari lansmanlar\u0131n\u0131<\/a> duyurduklar\u0131nda, hisse yat\u0131r\u0131mc\u0131 g\u00fcveniyle tepki verdi.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Belirsizlikten \u0130vmeye<\/h2>\n<p>Fennec&#8217;in hissesi son alt\u0131 ayda olduk\u00e7a dalgal\u0131 bir seyir izledi ve bu yolculu\u011fu anlamak potansiyel yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ok \u00f6nemli.<\/p>\n<p><strong>Ocak-Mart 2025<\/strong>: Hisse, yat\u0131r\u0131mc\u0131lar Avrupa geni\u015fleme planlar\u0131 hakk\u0131nda netlik beklerken 7-8 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc. Bu, ak\u0131ll\u0131 paran\u0131n pozisyon almaya ba\u015flad\u0131\u011f\u0131 birikim a\u015famas\u0131yd\u0131.<\/p>\n<p><strong>Nisan-Haziran 2025<\/strong>: <a href=\"https:\/\/www.pharmaceutical-technology.com\/news\/norgine-secures-pedmarqsi-licence-from-fennec-in-deal-worth-up-to-272m\/\">Norgine ile ortakl\u0131k anla\u015fmalar\u0131<\/a> sonu\u00e7 vermeye ba\u015flay\u0131nca ivme artt\u0131. Hisse fiyat\u0131 istikrarl\u0131 \u015fekilde 10-11 $ aral\u0131\u011f\u0131na y\u00fckseldi.<\/p>\n<p><strong>Temmuz-Eyl\u00fcl 2025<\/strong>: Patlama b\u00f6lgesi! 2. \u00e7eyrek kazan\u00e7lar beklentileri a\u015farken ve <a href=\"https:\/\/hearinghealthmatters.org\/hearing-news-watch\/2025\/pedmarqsi-hearing-loss-prevention-cisplatin\/\">klinik do\u011frulamalar artarken<\/a>, FRX 12 $&#8217;\u0131n \u00fczerine \u00e7\u0131karak Ocak diplerinden %60&#8217;tan fazla b\u00fcy\u00fcme g\u00f6sterdi.<\/p>\n<p>\u00d6nemli \u00e7\u0131kar\u0131m? Bu rastgele bir volatilite de\u011fil\u2014\u015firket b\u00fcy\u00fcme stratejisini hassasiyetle uyguluyor. Her fiyat hareketi somut i\u015f kilometre ta\u015flar\u0131na kar\u015f\u0131l\u0131k geldi.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<p>Mevcut ivme ve analist projeksiyonlar\u0131na dayanarak, Fennec Pharmaceuticals i\u00e7in gelecek yol \u015f\u00f6yle g\u00f6r\u00fcn\u00fcyor:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 15-18 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %20-45 yukar\u0131 potansiyel)<br \/> Avrupa geni\u015flemesi ve olas\u0131 Japonya deneme sonu\u00e7lar\u0131n\u0131n y\u0131l sonu ivmesi i\u00e7in m\u00fckemmel ko\u015fullar yaratmas\u0131 bekleniyor.<\/p>\n<p><strong>2026 Tahmini<\/strong>: 22-26 $ <br \/> <a href=\"https:\/\/www.tipranks.com\/stocks\/tse:frx\/forecast\">TipRanks analistleri ortalama hedef fiyat\u0131 19,51 $ olarak projeliyor<\/a>, ancak son performans nedeniyle ben daha iyimserim. Tam Avrupa lansman\u0131 ve potansiyel Asya pazar\u0131na giri\u015f bunu destekleyebilir.<\/p>\n<p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 35-42 $<br \/> Bu noktada Fennec, farkl\u0131 b\u00f6lgelerden birden fazla gelir ak\u0131\u015f\u0131yla k\u00fcresel bir varl\u0131k olu\u015fturmu\u015f olmal\u0131.<\/p>\n<p><strong>2030 Vizyonu<\/strong>: 50 $ ve \u00fczeri <br \/> PEDMARK d\u0131\u015f\u0131ndaki \u00fcr\u00fcn hatt\u0131n\u0131 ba\u015far\u0131yla geni\u015fletir ve uzmanl\u0131k alan\u0131n\u0131 korursa, bu hedef ula\u015f\u0131labilir hale gelir.<\/p>\n<p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Risk-getiri oran\u0131 mevcut seviyelerde birikimi destekliyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Mali Dalgalanma<\/strong>: Fennec, <a href=\"https:\/\/simplywall.st\/stocks\/ca\/pharmaceuticals-biotech\/tsx-frx\/fennec-pharmaceuticals-shares\">geriye d\u00f6n\u00fck olarak 16,53 milyon CA$ zarar<\/a> ile hala nakit yak\u0131yor. Biyoteknoloji giri\u015fimleri her zaman bu riskle kar\u015f\u0131 kar\u015f\u0131yad\u0131r.<\/li>\n<li><strong>Tek \u00dcr\u00fcn Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: \u015eirketin t\u00fcm i\u015fi \u015fu anda PEDMARK\/PEDMARQSI&#8217;ye dayan\u0131yor. Herhangi bir d\u00fczenleyici engel veya rekabet tehdidi y\u0131k\u0131c\u0131 olabilir.<\/li>\n<li><strong>Y\u00fcksek Beta Katsay\u0131s\u0131<\/strong>: 1,92 beta ile bu hisse, genel piyasadan neredeyse iki kat daha fazla hareket ediyor. Cesaret gerektirir.<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Patlay\u0131c\u0131 B\u00fcy\u00fcme<\/strong>: <a href=\"https:\/\/www.ainvest.com\/news\/fennec-pharmaceuticals-q2-2025-earnings-call-transcript-key-highlights-financial-results-2508\/\">%33 gelir art\u0131\u015f\u0131<\/a> 2. \u00e7eyrekte ticari ba\u015far\u0131n\u0131n i\u015faretidir.<\/li>\n<li><strong>K\u00fcresel Geni\u015fleme<\/strong>: \u0130ngiltere ve Almanya&#8217;daki ba\u015far\u0131l\u0131 lansmanlar ortakl\u0131k modelinin i\u015fe yarad\u0131\u011f\u0131n\u0131 g\u00f6steriyor. <a href=\"https:\/\/adisinsight.springer.com\/drugs\/800006630\">2025 ikinci yar\u0131s\u0131nda beklenen Japonya deneme sonu\u00e7lar\u0131<\/a> b\u00fcy\u00fck yeni pazar a\u00e7abilir.<\/li>\n<li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Pediatrik onkoloji d\u00fcnya \u00e7ap\u0131nda artan ilgi ve finansman al\u0131yor.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazlas\u0131n\u0131 FRX&#8217;e ay\u0131rmay\u0131n. Volatilite sayg\u0131 gerektirir.<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferde b\u00fcy\u00fck yat\u0131r\u0131m yapmak yerine, yat\u0131r\u0131m\u0131n\u0131z\u0131 birka\u00e7 haftaya yayarak giri\u015f fiyat\u0131n\u0131z\u0131 ortalay\u0131n.<\/li>\n<li><strong>5 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: 3. \u00e7eyrek kazan\u00e7lar i\u00e7in takviminize i\u015faret koyun. Tarihsel olarak bu olaylar m\u00fckemmel giri\u015f noktalar\u0131 yarat\u0131r.<\/li>\n<li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu h\u0131zl\u0131 kar ama\u00e7l\u0131 bir hisse de\u011fil. Tam b\u00fcy\u00fcme hikayesini yakalamak i\u00e7in en az 2-3 y\u0131l tutmay\u0131 planlay\u0131n.<\/li>\n<\/ol>\n<p>Ve favori t\u00fcccar bilgeli\u011fim: &#8220;Biyoteknoloji hisseleriyle ticaret yapmak, ergen \u00e7ocu\u011funuzun araba kullanmay\u0131 \u00f6\u011frenmesini izlemek gibidir\u2014heyecan verici ilerlemeler, hayat\u0131n\u0131z\u0131n t\u00fcm se\u00e7imlerini sorgulad\u0131\u011f\u0131n\u0131z anlarla kesintiye u\u011frar.&#8221;<\/p>\n<h2>\u2705 Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Platformunuzu Se\u00e7in<\/td>\n<td>FRX&#8217;in i\u015flem g\u00f6rd\u00fc\u011f\u00fc hem ABD hem Kanada borsalar\u0131na eri\u015fim sunan bir arac\u0131 kurum se\u00e7in<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Potansiyel kay\u0131plara haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n\u2014biyoteknoloji yat\u0131r\u0131m\u0131 risk ta\u015f\u0131r<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>FRX&#8217;i Aray\u0131n<\/td>\n<td>Kanada listesi i\u00e7in &#8220;FRX&#8221; veya ABD Nasdaq i\u00e7in &#8220;FENC&#8221; sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Piyasa emirleri yerine limit emirleri kullanarak giri\u015f fiyat\u0131n\u0131z\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Ger\u00e7ekle\u015ftirin<\/td>\n<td>Hisse adedi ve fiyat dahil emir detaylar\u0131n\u0131 iki kez kontrol edip onaylay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option FRX Yat\u0131r\u0131m\u0131 \u0130\u00e7in Neden Mant\u0131kl\u0131?<\/h2>\n<p>Fennec Pharmaceuticals gibi yenilik\u00e7i \u015firketlerde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option, bu yat\u0131r\u0131m stratejisiyle m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar.<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma Tutar\u0131 5 $<\/strong> &#8211; Bu inan\u0131lmaz d\u00fc\u015f\u00fck giri\u015f engeli, FRX pozisyonunuzu \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan olu\u015fturmaya ba\u015flaman\u0131z\u0131 sa\u011flar. Bu t\u00fcr volatil bir hisse i\u00e7in k\u00fc\u00e7\u00fck ba\u015flay\u0131p kademeli b\u00fcy\u00fcmek ak\u0131ll\u0131ca bir yakla\u015f\u0131md\u0131r.<\/li>\n<li><strong>1 Dakikal\u0131k KYC S\u00fcreci<\/strong> &#8211; Kas\u0131m ay\u0131ndaki kazan\u00e7 kataliz\u00f6r\u00fc gibi f\u0131rsatlar\u0131 h\u0131zl\u0131ca de\u011ferlendirmek i\u00e7in h\u0131zl\u0131 do\u011frulama gerekir. Pocket Option&#8217;\u0131n sadele\u015ftirilmi\u015f do\u011frulamas\u0131, ba\u015flaman\u0131z i\u00e7in g\u00fcnlerce beklemenizi engeller.<\/li>\n<li><strong>100+ Para \u00c7ekme Y\u00f6ntemi<\/strong> &#8211; Karlar\u0131 periyodik olarak almak veya kazan\u00e7lar\u0131 yeniden yat\u0131rmak isteseniz de, \u00e7oklu se\u00e7enekler biyoteknoloji portf\u00f6y\u00fcn\u00fcz\u00fc y\u00f6netmede esneklik sa\u011flar.<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, FRX yat\u0131r\u0131m\u0131n\u0131z\u0131 ger\u00e7ek zamanl\u0131 grafikler ve haber ak\u0131\u015flar\u0131yla takip etmeyi kolayla\u015ft\u0131r\u0131r ve \u015firket geli\u015fmelerinden haberdar olman\u0131z\u0131 sa\u011flar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Fennec: Sadece Bir \u0130la\u00e7 Hissesi De\u011fil<\/h2>\n<p>Fennec Pharmaceuticals sa\u011fl\u0131k alan\u0131nda benzersiz bir konuma sahip. Kanseri tedavi etmeye \u00e7al\u0131\u015fm\u0131yorlar\u2014kanser tedavisini \u00e7ocuklar i\u00e7in daha katlan\u0131labilir hale getiriyorlar. Amiral gemisi \u00fcr\u00fcnleri PEDMARK, pediatrik hastalarda sisplatin kaynakl\u0131 i\u015fitme kayb\u0131n\u0131 \u00f6nlemek i\u00e7in FDA onayl\u0131 ilk ve tek terapiyi temsil ediyor.<\/p>\n<p>\u015eirketin stratejik oda\u011f\u0131 <strong>do\u011frudan tedavi yerine destekleyici bak\u0131m<\/strong> \u00fczerine. Herkes yeni kanser ila\u00e7lar\u0131 geli\u015ftirmek i\u00e7in yar\u0131\u015f\u0131rken, Fennec tedavi s\u0131ras\u0131nda ya\u015fam kalitesini koruma gibi g\u00f6zden ka\u00e7an ama kritik bir ihtiyac\u0131 belirledi.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Fennec&#8217;in y\u00f6netim ekibi Kuzey Carolina genel merkezlerinde parf\u00fcm p\u00fcsk\u00fcrten asans\u00f6rler kurdu\u2014her katta farkl\u0131 bir koku yay\u0131l\u0131yor ve \u00e7al\u0131\u015fanlar haftal\u0131k favorilerini oyluyor. \u00c7\u00fcnk\u00fc \u00e7ocuklar\u0131n i\u015fitmesini kurtar\u0131yorsan\u0131z, \u00e7al\u0131\u015fma ortam\u0131n\u0131n da harika kokmas\u0131n\u0131 neden istemeyesiniz ki?<\/p>\n"},"faq":[{"question":"Fennec Pharmaceuticals hisseleri nereden al\u0131nabilir?","answer":"Fennec Pharmaceuticals hisseleri, ABD Nasdaq ve Kanada borsalar\u0131nda i\u015flem g\u00f6rmektedir. Bu borsalara eri\u015fim sa\u011flayan arac\u0131 kurumlar \u00fczerinden al\u0131m yap\u0131labilir."},{"question":"Fennec Pharmaceuticals'\u0131n ana \u00fcr\u00fcn\u00fc nedir?","answer":"\u015eirketin ana \u00fcr\u00fcn\u00fc PEDMARK, pediatrik kanser hastalar\u0131nda sisplatin kaynakl\u0131 i\u015fitme kayb\u0131n\u0131 \u00f6nleyen FDA onayl\u0131 ilk ve tek ila\u00e7t\u0131r."},{"question":"Fennec hisseleri i\u00e7in \u00f6nemli tarih nedir?","answer":"5 Kas\u0131m 2025, Fennec'in 3. \u00e7eyrek kazan\u00e7 raporunun a\u00e7\u0131klanaca\u011f\u0131 \u00f6nemli bir tarihtir ve hisse fiyat\u0131 \u00fczerinde etkili olabilir."},{"question":"Fennec hisselerine yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Yat\u0131r\u0131m yaparken volatiliteye dikkat etmeli, k\u00fc\u00e7\u00fck ba\u015flay\u0131p dolar maliyeti ortalamas\u0131 yapmal\u0131 ve uzun vadeli d\u00fc\u015f\u00fcnmelisiniz."},{"question":"Pocket Option Fennec yat\u0131r\u0131m\u0131 i\u00e7in neden tercih edilmeli?","answer":"Pocket Option, d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci ve \u00e7oklu para \u00e7ekme y\u00f6ntemleri ile Fennec gibi volatil hisselerde yat\u0131r\u0131m yapmay\u0131 kolayla\u015ft\u0131r\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Fennec Pharmaceuticals hisseleri nereden al\u0131nabilir?","answer":"Fennec Pharmaceuticals hisseleri, ABD Nasdaq ve Kanada borsalar\u0131nda i\u015flem g\u00f6rmektedir. Bu borsalara eri\u015fim sa\u011flayan arac\u0131 kurumlar \u00fczerinden al\u0131m yap\u0131labilir."},{"question":"Fennec Pharmaceuticals'\u0131n ana \u00fcr\u00fcn\u00fc nedir?","answer":"\u015eirketin ana \u00fcr\u00fcn\u00fc PEDMARK, pediatrik kanser hastalar\u0131nda sisplatin kaynakl\u0131 i\u015fitme kayb\u0131n\u0131 \u00f6nleyen FDA onayl\u0131 ilk ve tek ila\u00e7t\u0131r."},{"question":"Fennec hisseleri i\u00e7in \u00f6nemli tarih nedir?","answer":"5 Kas\u0131m 2025, Fennec'in 3. \u00e7eyrek kazan\u00e7 raporunun a\u00e7\u0131klanaca\u011f\u0131 \u00f6nemli bir tarihtir ve hisse fiyat\u0131 \u00fczerinde etkili olabilir."},{"question":"Fennec hisselerine yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Yat\u0131r\u0131m yaparken volatiliteye dikkat etmeli, k\u00fc\u00e7\u00fck ba\u015flay\u0131p dolar maliyeti ortalamas\u0131 yapmal\u0131 ve uzun vadeli d\u00fc\u015f\u00fcnmelisiniz."},{"question":"Pocket Option Fennec yat\u0131r\u0131m\u0131 i\u00e7in neden tercih edilmeli?","answer":"Pocket Option, d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci ve \u00e7oklu para \u00e7ekme y\u00f6ntemleri ile Fennec gibi volatil hisselerde yat\u0131r\u0131m yapmay\u0131 kolayla\u015ft\u0131r\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T16:14:07+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-09-01T16:14:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/\",\"name\":\"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-09-01T16:14:07+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/","og_locale":"tr_TR","og_type":"article","og_title":"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T16:14:07+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-09-01T16:14:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/","name":"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-09-01T16:14:07+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Fennec Pharmaceuticals Inc. (FRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Fennec Pharmaceuticals Inc. (FRX) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":368626,"slug":"how-to-buy-fennec-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Fennec Pharmaceuticals Inc. (FRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Fennec Pharmaceuticals Inc. (FRX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":368624,"slug":"how-to-buy-fennec-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Fennec Pharmaceuticals Inc. (FRX) - Investimento em a\u00e7\u00f5es da Fennec Pharmaceuticals Inc. (FRX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-fennec-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/368620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=368620"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/368620\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=368620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=368620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=368620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}